KNBI.F Stock Overview
Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Kane Biotech Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.09 |
| 52 Week High | CA$0.12 |
| 52 Week Low | CA$0.042 |
| Beta | 0.54 |
| 1 Month Change | 22.01% |
| 3 Month Change | n/a |
| 1 Year Change | -0.056% |
| 3 Year Change | -40.88% |
| 5 Year Change | 70.82% |
| Change since IPO | -84.84% |
Recent News & Updates
Recent updates
Shareholder Returns
| KNBI.F | US Biotechs | US Market | |
|---|---|---|---|
| 7D | 0% | -2.5% | -3.2% |
| 1Y | -0.06% | -3.7% | 19.3% |
Return vs Industry: KNBI.F exceeded the US Biotechs industry which returned -3.7% over the past year.
Return vs Market: KNBI.F underperformed the US Market which returned 19.3% over the past year.
Price Volatility
| KNBI.F volatility | |
|---|---|
| KNBI.F Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 11.6% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: KNBI.F's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine KNBI.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | n/a | Marc Edwards | kanebiotech.com |
Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops pet oral care products under the StrixNB and bluestem brands; and animal and human wound care solutions under the DispersinB name. It also offers scalp care products under the DermaKB brand name; and wound care products under the Coactiv+ brand name, as well as other products under the goldstem, silkstem, Aledex, and DermaKB Biofilm brand names.
Kane Biotech Inc. Fundamentals Summary
| KNBI.F fundamental statistics | |
|---|---|
| Market cap | US$12.94m |
| Earnings (TTM) | -US$3.32m |
| Revenue (TTM) | US$108.35k |
119.5x
P/S Ratio-3.9x
P/E RatioIs KNBI.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| KNBI.F income statement (TTM) | |
|---|---|
| Revenue | CA$148.98k |
| Cost of Revenue | CA$39.51k |
| Gross Profit | CA$109.47k |
| Other Expenses | CA$4.67m |
| Earnings | -CA$4.56m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.035 |
| Gross Margin | 73.48% |
| Net Profit Margin | -3,062.39% |
| Debt/Equity Ratio | -98.4% |
How did KNBI.F perform over the long term?
See historical performance and comparison